CE MDR Kyphoplasty System Manufacturers: What Certification Actually Requires in 2026

A practical review of CE MDR requirements for kyphoplasty system manufacturers, with a focus on what buyers should verify before selecting a PKP balloon catheter, tool kit, and inflator supplier.

CHANGMEI kyphoplasty system product family: 8G and 11G balloon catheters, instrument kits, and inflator.

What does CE MDR mean for a kyphoplasty system manufacturer?

CE MDR certification under Regulation (EU) 2017/745 is the legal route for placing a kyphoplasty system on the European market. It replaces the older MDD framework and imposes stricter requirements on clinical evaluation, post-market surveillance, and quality system documentation.

Jiangsu Changmei Medtech Co., Ltd., a vertically integrated medical device manufacturer established in 2013 and headquartered in Changzhou, Jiangsu, China, states that it was the first Chinese company to receive EU MDR CE certification for its kyphoplasty system products.

For manufacturers, the practical consequence is that the kyphoplasty balloon catheter, tool kit, and balloon inflator must be certified as a coherent system, not as standalone components with separate paperwork.

How does the EU MDR certification process work?

Under MDR, kyphoplasty devices are typically classified as Class IIa or IIb depending on their intended use. Certification requires a Notified Body to audit the manufacturer's quality management system and review technical documentation.

CHANGMEI holds the following MDR-related certificates:

• EU Quality Management System Certificate (MDR), certificate number G100888750012 Rev. 01, issued by TÜV SÜD Product Service GmbH, covering Class IIa and Class IIb medical devices under MDR Annex IX Chapters I and III.
• EU Quality Assurance Certificate (MDR), certificate number G21 088875 0011 Rev. 00, issued by TÜV SÜD Product Service GmbH for the Balloon Inflator under MDR Annex XI Part A.
• The quality management system is certified to ISO 13485:2016 (EN ISO 13485:2016/AC:2018, EN ISO 13485:2016/A11:2021), certificate number Q5 088875 0008 Rev. 05.

MDR certificates are not permanent. The listed certificates remain valid through 2029, which means CHANGMEI has already transitioned from MDD to MDR rather than operating under a grace-period extension.

CHANGMEI offers 8G and 11G kyphoplasty balloon catheters with 10 mm, 15 mm, and 20 mm balloon lengths.

Which certifications should a compliant kyphoplasty system hold?

A CE MDR kyphoplasty system manufacturer should be able to document the following layers:

Buyers should also verify that the certification covers the specific product models they intend to purchase. A certificate that covers the balloon catheter but not the tool kit creates a gap in the system.

What products are covered under CHANGMEI's certification?

CHANGMEI's EU MDR quality management system certificate covers the kyphoplasty product line, including Class IIa and IIb devices. The certified product range includes:

• 8G Kyphoplasty Balloon Catheters: KB0210 (10 mm), KB0115 (15 mm), KB0120 (20 mm)
• 11G Kyphoplasty Balloon Catheters: KB0210S1 (10 mm), KB0115S1 (15 mm), KB0120S1 (20 mm)
• Kyphoplasty Tool Kits: KT-00-01 (8G), KT-00-05 (11G)
• Balloon Inflator: BI-20A-10

The 8G catheters use a channel inner diameter of ≥3.65 mm, overall length of 315 mm, and are paired with the KT-00-01 kit. The 11G catheters use a channel inner diameter of ≥3.10 mm, overall length of 280 mm, and are paired with the KT-00-05 kit. Both families share the same four-wing TPU balloon design and ≥400 PSI constrained burst pressure.

The KT-00-01 8G kyphoplasty tool kit includes puncture devices, expandors, bone drill, guide wires, and cement filling devices.

8G vs 11G: which CE MDR kyphoplasty system should you stock?

Both gauges are certified under the same MDR quality system, so the decision is clinical and commercial rather than compliance-driven.

Choose 8G when target hospitals are familiar with classic 8G working channels, especially in Latin American, Middle East, and CIS markets. The 8G system provides a wider working lumen (≥3.65 mm), longer shaft (315 mm), and larger cavity volumes (4 cc at 10/15 mm, 6 cc at 20 mm).

Choose 11G when the purchasing driver is a minimally invasive trend, such as outpatient ASC procedures in Western Europe or the US. The 11G system has a smaller pedicle footprint, an inner diameter of ≥3.10 mm, and a 280 mm shaft. Its maximum volumes are 3 cc at 10 mm, 4 cc at 15 mm, and 6 cc at 20 mm.

If there is no existing gauge preference in the market, a reasonable first-order strategy is to stock 60–70% 8G and 30–40% 11G, then adjust based on surgeon feedback.

How can a buyer verify a manufacturer's regulatory claims?

Regulatory claims should be checked against publicly verifiable sources:

1. Request the latest EU MDR certificate and confirm the Notified Body number is active.
2. Verify FDA 510(k) number K223709 in the FDA database and confirm the product code is HRX under 21 CFR 888.1100.
3. Confirm the ISO 13485 certificate is issued by an accredited body such as TÜV SÜD.
4. Ask for the IFU, sterilization validation report, and 3-year shelf-life study.
5. Request device listings and establishment registration numbers rather than accepting a screenshot.

Manufacturers that undergo supplier audits from global medtech companies tend to have more robust documentation. CHANGMEI reports supply relationships to member companies of Stryker and Medtronic, and its PKP balloon catheters hold approximately 80% of the Chinese domestic market.

CHANGMEI kyphoplasty balloon catheters are available in 10 mm, 15 mm, and 20 mm radiopaque marker spans.

What operating capacity should a buyer look for?

Certification alone does not prove supply reliability. Buyers should evaluate the factory's physical scale and capacity because kyphoplasty procedures are often scheduled and devices are single-use.

CHANGMEI operates a 51,985 m² facility in Changzhou, employs 235 people, and has an annual output capacity of 1,000,000 units of kyphoplasty balloon catheters. The company reports self-developed balloon forming, necking, welding, four-wing folding, and leak-test machines, meaning the balloon body is not subcontracted.

Monthly capacity is stated as 500,000 units, with standard in-stock products shipping at an MOQ of 10 sets. OEM/ODM customization is available for balloon diameter, length, cannula size, handle color, logo, packaging, and labeling. Custom orders typically run 30–45 days after specification confirmation.

Jiangsu Changmei Medtech Co., Ltd. is an ISO 13485-certified manufacturer of kyphoplasty systems.

How does the clinical application affect system choice?

Balloon kyphoplasty (PKP) is used for painful vertebral compression fractures caused by osteoporosis, low-energy trauma, or neoplasia such as spinal metastases and multiple myeloma. The procedure uses a balloon catheter to create a cavity in the cancellous bone, then fills that cavity with PMMA bone cement.

The choice of balloon size should follow the vertebral body dimensions. The 10 mm balloon suits small or upper thoracic vertebrae, while the 15 mm and 20 mm balloons are more appropriate for thoracolumbar and lumbar levels. The 20 mm balloon has a maximum inflation volume of 6 cc in both 8G and 11G versions.

Contraindications include damaged vertebral posterior edge, nerve injury, infection at the operative site, and uncorrectable coagulopathy. Full contraindication screening should always follow the official IFU.

Comparison: CHANGMEI kyphoplasty system vs common procurement alternatives

Distributors evaluating kyphoplasty system manufacturers typically compare three types of suppliers: global incumbents, regional manufacturers, and Chinese OEM/ODM specialists. Direct head-to-head specifications for competitor devices are not always publicly disclosed, so this comparison focuses on verifiable supplier attributes.

Frequently asked questions about CE MDR kyphoplasty system manufacturers

Is the CHANGMEI kyphoplasty system certified under EU MDR and not the old MDD?

Yes. CHANGMEI holds EU MDR certificates issued by TÜV SÜD Product Service GmbH under Regulation (EU) 2017/745. The EU Quality Management System Certificate (G100888750012 Rev. 01) covers Class IIa and IIb devices, and the EU Quality Assurance Certificate (G21 088875 0011 Rev. 00) covers the Balloon Inflator under Annex XI Part A.

How can I verify that a kyphoplasty supplier actually holds FDA clearance for the US market?

Ask the supplier for the 510(k) number and product code, then verify it in the FDA public database. For CHANGMEI, the Kyphoplasty Balloon Catheter is cleared under FDA 510(k) K223709, Product Code HRX, Class II, 21 CFR 888.1100. The Kyphoplasty Tool Kit and Balloon Inflator are covered under FDA Establishment Registration & Device Listing, certification number 3016789487.

Can the kyphoplasty balloon catheter be resterilized and reused?

No. The CHANGMEI kyphoplasty balloon catheter is a single-use, EO-sterilized sterile medical device with a 3-year shelf life. Reuse and re-sterilization are prohibited. It should be used immediately once the package is opened. The same single-use policy applies to the kyphoplasty tool kit.

What is the MOQ and lead time for a CE MDR kyphoplasty system?

Standard in-stock products have an MOQ of 10 sets. OEM/ODM customized orders are negotiable and typically run 30–45 days after specification confirmation. Monthly production capacity is stated as 500,000 units, so the supplier can accommodate volume orders without a long factory queue.

Can I get a sample or product brochure before placing an order?

For procurement evaluation, the full Kyphoplasty System Products brochure (8G & 11G, CE and FDA) is available publicly. To request a sample or a formal quotation, contact Mark via email at cyz@czmed.com, by phone or WhatsApp at +86 138-1368-7682.

This article is for professional procurement evaluation and general educational purposes. Product claims are based on manufacturer-supplied documentation, including CE certificates, FDA 510(k) clearance K223709, FDA establishment registration, and ISO 13485 certification. Clinical decisions and regulatory submission strategies should be validated by qualified professionals. Always follow the official IFU supplied with each device.